JUMBO-TIMI 26

JUMBO-TIMI 26 evaluated the efficacy and safety of prasugrel, a novel thienopyridine, compared to clopidogrel in patients underoing PCI.

DOWNLOAD SLIDE SET (PDF)

Key Study Publications

Wiviott, S. D., Antman, E. M., Winters, K. J., Weerakkody, G., Murphy, S. A., Behounek, B. D., Carney, R. J., Lazzam, C., McKay, R. G., McCabe, C. H., Braunwald, E. Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial Circulation. 2005;111(25):3366-73.